# Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies.

> **NCT00739141** · PHASE2 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 86 (actual)

## Conditions studied

- Leukemia
- Myelodysplastic Syndrome
- Non-Hodgkins Lymphoma
- Chronic Myelogenous Leukemia
- Hodgkins Lymphoma

## Interventions

- **DRUG:** fludarabine, cyclophosphamide, thiotepa, radiation therapy, unrelated donor umbilical cord blood graft

## Key facts

- **NCT ID:** NCT00739141
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08-12
- **Primary completion:** 2021-10-15
- **Final completion:** 2021-10-15
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2022-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00739141

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00739141, "Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00739141. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*